Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies

Journal of Immunological Methods

Volumn 197, Issue 1-2, 1996, Pages 69-83

  Vallera, Daniel A ^a,d   Burns, Linda J ^a   Frankel, Arthur E ^b   Sicheneder, Andrew R ^a   Gunther, Roland ^c   Gajl Peczalska, K ^d   Pennell, Christopher A ^d   Kersey, John H ^a,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

acute lymphoblastic leukemia; cancer theapy; human; immunotherapy; immunotoxin; mouse; ricin; scid scid; T cell

Indexed keywords

CD7 ANTIGEN; IMMUNOTOXIN; MONOCLONAL ANTIBODY; RICIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CASE REPORT; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; T CELL LEUKEMIA;

ANIMALIA;

EID: 0030590640     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-1759(96)00127-5     Document Type: Article

References (24)

1. Amlot, P.L., Stone, M.J., Cunningham, D., Fay, J., Newman, R., Collins, R., May, R., McCarthy, M., Richardson, J., Ghetie, V., Ramilo, O., Thorpe, P.E., Uhr, J.W. and Vitetta, E.S. (1993) Phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood 82, 2624.
2. Blakey, D.C., and Thorpe, P.E. (1988) Prevention of carbohydrate-mediated clearance of ricin -containing immunotoxins by the liver. In: A.E. Frankel (Ed.), Immunotoxins. Kluwer Academic, Boston, MA, p. 457.
3. Buchanan, G. (1990) Diagnosis and management of acute lymphoblastic leukemia. Hematol. Oncol. Clin. N. Am. 4, 75.
4. Byers, V.S., Henslee, P.J., Kernan, N., Blazar, B.R., Gingrich, R., Phillips, G.L., LeMaistre, C.R., Gilliland, G., Antin, J.J., Vogelsang, G., Martin, P., Tutschka, P.J., Trown, P., Ackerman, S.K., O'Reilly, R.J. and Scannon, P.J. (1990) Use of an anti-pan T lymphocyte ricin A chain immunotoxin as targeted immunotherapy in steroid resistant acute graft versus host disease. Blood 75, 1426.
5. Carlsson, J., Drevin, H. and Axen, R. (1978) Protein thiolation and reversible protein-protein conjugation. Biochem. J. 173, 723.
6. Flavell, D.J., Boehm, D.A., Emery, L., Noss, A. and Flavell, S.U. (1995) Comparison of the therapeutic efficacy of anti-CD7-saporin immunotoxins constructed with one or two saporin moieties per immunotoxin molecule in SCID mice with human T-cell acute leukemia [abstract}. Fourth International Symposium on Immunotoxins. Myrtle Beach, South Carolina.
7. 2, and B chains and characterization of their toxicity. J. Biol. Chem. 261, 5314.
8. Ghetie, V., Swindel, E., Uhr, J.W. and Vitetta, E.S. (1993) Purification and properties of immunotoxins containing one vs. two deglycosylated ricin A chains. J. Immunol. Methods 166, 117.
9. Jansen, B., Vallera, D.A., Jaszcz, W.B., Nguyen, D. and Kersey, J.H. (1992) Successful treatment of human acute T-cell leukemia in SCID mice using anti-CD7-deglycosylated ricin A-chain immunotoxin DA7. Cancer Res. 52, 1314.
10. Haynes, B.F., Denning, S.M, Singer, K.H. and Kurtzberg, J. (1989) Ontogeny of T-cell precursors: A model for the initial stages of human T-cell development. Immunol. Today 10, 87.
11. Mantel, N. (1966) Evaluation of survival data in two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50, 163.
12. Markwell, M.A.K. (1982) A new solid state reagent to iodinate proteins: conditions for the efficient labeling of antiserum Anal. Biochem. 125, 427.
13. Myers, D.E., F.M. Uckun, S.E. Swaim and D.A. Vallera (1989) The effects of aromatic and aliphatic maleimide crosslinkers on anti-CD5 ricin immunotoxins. J. Immunol. Methods 121, 129.
14. Myers, D.E., Yanishevski, Y., Masson, E., Irvin, J.D., Evans W.E. and Uckun F.M. (1995) Favorable pharmacodynamic features and superior anti-leukemic activity of B43 (anti-CD19) immunotoxins containing two pokeweed antiviral protein molecules covalently linked to each monoclonal antibody molecule. Leukemia Lymphoma 18, 93.
15. Pelham, H.R. and Jackson, P.J. (1976) An efficient mRNA-dependent translation system from reticulocyte lysates. Eur. J. Biochem. 67, 247.
16. Schmidberger, H., King, L., Lasky, L.C. and Vallera, D.A. (1990) Anti-tumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo Cancer Res. 50, 3249.
17. Schmidberger, H., Buchsbaum, D.J., Blazar, B.R., Everson, P. and Vallera, D.A. (1991) Radiotherapy in mice with Yttrium-90 labeled anti-Ly1 monoclonal antibody: Therapy of the T cell lymphoma EL4. Cancer Res. 51, 1883.
18. Thorpe, P., Blakey, D., Brown, A., Knowles, P., Knyba, R., Wallace, P., Watson, G. and Wawrzynaczak, E. (1987a) Comparison of two anti-thy 1.1-Abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants. J. Natl. Cancer Inst. 79, 1101.
19. Thorpe, P., Wallace, P., Knowles, P., Relf, M., Brown, A., Watson, G., Knyba, R., Wawrzynczak, E. and Blakey, D. (1987b) New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Res. 47, 5924.
20. Thorpe, P.E., Wallace, P.M., Knowles. P.P., Relf, M.G., Brown. A.N.F., Watson, G.J., Blakey, D.C. and Newell, D.R. (1988) Improved antitumor effects of immunotoxins prepared with deglycosylated ricin A chain and hindered disulfide linkages Cancer Res. 48, 6396.
21. Uckun, F.M., Stong, R.C., Youle, R.J. and Vallera, D.A. (1985) Combined ex vivo treatment with immunotoxins and mafosfamid: A novel immunochemotherapeutic approach for elimination of neoplastic T-cells from autologous marrow grafts. J. Immunol. 134, 3504.
22. Uckun, F.M., Kersey, J.H., Vallera, D.A., Ledbetter, J.A., Weisdorf, D., Myers, D.E., Haake, R. and Ramsay, N.K.C. (1990) Autologous bone marrow transplantation in high risk remission T-lineage ALL using immunotoxins plus 4-HC for marrow purging: I. Application of multiparameter flow cytometry and colony assays for a quantitative analysis of autografts for the presence of residual T-lineage leukemic lymphoid progenitor cells. Blood 79, 1723.
23. Uckun, F., Sather, H., Reaman, G., Shutter, J., Land, V., Trigg, M., Gunther, R., Chelstrom, L., Bleyer, A. and Gagnon, P. (1995) Leukemic cell growth in SCID mice as a predictor of relapse in high risk B-lineage acute lymphoblastic leukemia. Blood 85, 873.
24. Vitetta, E.S., Stone, M., Amlot, P., May, R., Till, M., Newman, J., Clark, P., Collins, R., Cunningham, D., Ghetie, V., Uhr, J.W. and Thorpe, P.E. (1991) Phase I immunotoxin trial in patients with B-cell lymphoma. Cancer Res. 51, 4052.